In GBM, where BRCA1/2 functional mutations/deletions are rare (≤1%)15, PARPi merely exerts strong anti-GBM effects in a few cases, such as those with IDH1/2 mutations16. The gene discussed is BRCA1; the disease is glioblastoma.